News
The Clinical Research Unit in Clinical Trials gets the ISO 9001:2015 certification
The UICEC of IDIBELL is functionally dependent on the Clinical Pharmacology Service of the Bellvitge University Hospital and led by Dr. Pilar Hereu
The Scientific and Technological Conference of L’Hospitalet awards two research projects co-tutored by IDIBELL
The research projects have been performed by high school students from the Bellvitge and Mercè Rodoreda Institutes
The Bellvitge Institute, with whom IDIBELL has an educational Tandem, receives an honorable mention in the framework of the Conference
The Biomedical Cluster wants to promote an innovative health ecosystem, a benchmark in personalized medicine
The promoter group works on the consolidation and empowerment of the biosanitary hub of L’Hospitalet and Esplugues de Llobregat. The project will be presented to the European recovery funds Next Generation.
Oncommun receives the Francisco del Pozo award from EIT Health Spain as the best 2020 Education Program
This collaboration project between ICO, IDIBELL and the University of Barcelona (UB) has resulted in the ICOnnecta’t platform.
A study by IDIBELL and Bellvitge University Hospital identifies iron deficiency as a key element in the progression of heart failure
The study, published on Cell & Bioscience, includes two experimental approaches, one with mice and the other one with cell cultures. This discovery may be the basis for the development of better treatments for this disease and means a paradigm shift.
New chair to promote research in precision radiation oncology
Today, the UB and the biomedical company Atrys Health, specialized in precision medicine, have signed a collaboration agreement to create the Personalized Radiotherapy Chair, which will be led by Ferran Guedea, head of the IDIBELL Radiobiology and Cancer Group.
Five IDIBELL’s projects receive funding from La Marató 2020 dedicated to COVID-19
IDIBELL will receive almost 630,000 euros from La Marató de TV3 and Catalunya Radio to carry out five projects. The funded studies will focus on the research of factors to predict COVID-19 complications and testing vaccines in vulnerable patients.
IDIBELL researchers participate in a study that describes a new mechanism of resistance to hepatocellular carcinoma treatment
Identification of the miR-518d-5p molecule in blood is associated with increased resistance to sorafenib treatment and reduced overall survival in patients with hepatocellular carcinoma
Science and performing arts against stereotypes
A study by IDIBELL and UB shows that participation in a workshop combining scientific training and theatre performance reduces implicit biases against physical illnesses